Status not kept up to date
Robotic Assisted Transanal Total Mesorectal Excision Surgery for Rectal Cancer in Low Site
NCT03422835 · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Updated 6 Feb 2018
- What is being tested
- R-TME; R-TaTME
- For
- Rectal Neoplasms
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years to 80 years. About 50 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 15 Feb 2018, ends 30 Dec 2023. Registered 6 Feb 2018.
- Results
- None posted yet.
In the researchers' words
To investigates the feasibility, practicability, safety and subjective as well as functional outcome of Robotic transanal total mesentery excision for rectal cancer in low site.